Novartis (NVS) traded higher on Tuesday after remibrutinib, its FDA-approved treatment for a skin condition known as "hives," succeeded in two Phase 3 trials for patients with multiple sclerosis, a ...

A therapeutic approach pioneered in Mainz for the treatment of multiple sclerosis (MS) is taking an important step toward clinical application.

Meta: Ponvory treatment for up to 13 years was associated with low MS disease activity in adults with relapsing-remitting ...

Early treatment with high-efficacy MS drugs cut the risk of relapse, but not disability progression independent of relapse ...

Researchers have found a potential new way to improve the treatment of multiple sclerosis (MS) using a novel combined therapy. The results build on two harmonized Phase I clinical trials, focusing on ...

Scientists hunting for treatments and cures for multiple sclerosis may have found an unlikely ally — the yak. The high-altitude, cold-hardy relative of the cow could be the key to a medical ...

Add Yahoo as a preferred source to see more of our stories on Google. BUFFALO, N.Y. (WIVB) — More than a thousand people gathered at Terminal B at the Outer Harbor with one goal in mind Saturday ...

WALTHAM, Mass., March 12, 2025 /PRNewswire/ -- People who are caring for loved ones with multiple sclerosis (MS) now have an additional resource to answer their questions at any time. In addition to ...

Multiple sclerosis (MS) is a chronic disease of the central nervous system that causes disruptions in the flow of information within the brain and between the brain and body, eventually causing ...

HOUSTON & WALTHAM, Mass.--(BUSINESS WIRE)--Biostate AI, a leading innovator in artificial intelligence for RNA sequencing, today announced a strategic partnership with the Accelerated Cure Project ...

While there's currently no cure for multiple sclerosis, a lot of new treatment options have become available—many in just the last few years. There are pills and capsules taken daily or even a few ...